Searched for
MANISH DHANUKA
Bling without the sting: How Gen Z is redefining gold glamGen Z's demand for affordable, trend-driven jewelry is reshaping India's market, with fast-fashion options gaining popularity. Brands are f...- Orchid Pharma shares in focus as U.S. FDA completes facility inspectionOrchid Pharma share price: Orchid Pharma's Alathur facility is the only U.S. FDA-approved manufacturing site in India for sterile cephalosp...
- Budget 2025: Over 50 stocks stand to gain as FM unveils consumption booster shot for India's growthUnion Budget 2025 brings opportunities for several sectors. Auto stocks may benefit from increased income tax slabs. Consumer durables, hea...
- Budget Delights: 30 stocks poised to benefit from FM Sitharaman's announcementsDespite maintaining steady capital expenditure and fiscal deficit targets, analysts predict that significant tax policy changes, particular...
- Agriculture stocks rally up to 9% as Sitharaman allots Rs 1.52 lakh crore to sector in BudgetIn her Budget speech, Sitharaman said the government, in partnership with states, will promote digital public infra for agriculture. Follow...
- Markets moving away from consumption themes to investment themes: Manish SonthaliaBut otherwise, automobiles, banks, pharmaceuticals, capital goods they have all delivered on numbers. Metals and oil and gas was again supp...
- Debt-free Orchid Pharma charts out growth planOrchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch...
- Orchid Pharma's new antibiotic 'Exblifeb' gets European Medicines Agency approvalThe Chennai-based firm said Exblifeb incorporates Enmetazobactam, "the first completely invented-in-India Beta Lactamase inhibitor" and it ...
- Orchid all set to generate enough cash to fund expansion plans: Manish Dhanuka“Three years back, when we started, we had a significant debt. But, today we are a debt-free company and we also have significant investmen...
- ET Global Indian Leaders 2022 recognised entrepreneurial excellence across industriesET Global Indian Leaders is a celebration of professional and entrepreneurial excellence across multiple sectors and industries.
- Ahead of Market: 12 things that will decide stock action todayNirali Shah of Samco Securities said the index has established short-term support at 15,500 level, and a breach of this level will raise th...
- Ahead of Market: 12 things that will decide stock action on WednesdayNifty managed to top the 15,900 level in intraday trade, but failed to hold the gains and ended above the 15,800 level.
- Ahead of Market: 12 things that will decide stock action on MondayNifty moved in a wide range of 311 points and formed a ‘Hammer’ candle on the daily chart and an indecisive 'Doji' on the weekly scale. Ana...
- Ahead of Market: 12 things that will decide stock action on ThursdaySensex slipped below the 52,000 mark, while Nifty ended below the crucial 15,550 level.
- Ahead of Market: 12 things that will decide stock action on WednesdayManish Hathiramani, Technical Analyst at Deen Dayal Investments, said, a breach of the 15,300 level can open up doors for 15,550-15,600 lev...
- Ahead of Market: 12 things that will decide stock action on FridayShrikant Chouhan, Executive Vice President (Equity Technical Research), Kotak Securities said, “On the downside, 13,000 and 12,930 would be...
- Ahead of Market: 12 things that will decide stock action on FridayMazhar Mohammad of Chartviewindia.in said, in next trading session, if the index settles below 12,800 levels on closing basis, then it may ...
- Ahead of Market: 12 things that will decide stock action on WednesdayAjit Mishra of Religare Broking said, the rebound in Nifty indicates that the prevailing consolidation phase will continue.
- Stocks in the news: Neogen Chemicals, Vedanta, ZEEL, Vakrangee and RBL BankAmbit Capital has maintained sell rating on Bharti Airtel with a target price of Rs 284.
Load More
